no weight loss on tirzepatide Why Plateaus Semaglutide or Tirzepatide for Weight Loss |
Description
Many patients report meaningful reductions in body weight, which is particularly important since obesity is a common comorbidity in type 2 diabetes

C., Allen, S., Sarker, E., Wu, Q., Stefanski, A., Jouravskaya, I., & ATTAIN-2 Trial Investigators (2026)

Why Wegovy Matters for South Africa 2

Founded in 1923, it is a Danish multinational pharmaceutical company headquartered in Bagsvrd, Denmark, with production facilities in 9 countries and affiliates or offices in 5 countries

The prevalence of people being overweight and obese increases with age up to age 64, reaching the peak in the 55 to 64 years group (72.8% and 32.4% respectively)

References Eshak N, Irani A, Sullivan M
